(Total Views: 491)
Posted On: 02/27/2021 10:34:33 PM
Post# of 155761
Hey Daltondog,
Understood about the 2-4 week testing timeframe in your example. But can you answer this question?
How is it possible that a trial drug reduces bad outcomes (SAEs) over placebo? Was the placebo or SOC poisonous in some way? Or was the trial drug showing some promising affect in the subjects that received the trial drug?
How did Leronlimab lessen bad outcomes over placebo in CD10 if it wasn’t doing something better than SOC/placebo?
Thanks,
Chazzle
Understood about the 2-4 week testing timeframe in your example. But can you answer this question?
How is it possible that a trial drug reduces bad outcomes (SAEs) over placebo? Was the placebo or SOC poisonous in some way? Or was the trial drug showing some promising affect in the subjects that received the trial drug?
How did Leronlimab lessen bad outcomes over placebo in CD10 if it wasn’t doing something better than SOC/placebo?
Thanks,
Chazzle
(0)
(0)
